NOT FOR DISTRIBUTION
Header cover image

CompuGroup Medical SE KGaA

Market Cap

€3.8b

Last Updated

2021/04/15 18:11 UTC

Data Sources

Company Financials +

Executive Summary

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. More Details


Snowflake Analysis

Adequate balance sheet average dividend payer.


Similar Companies

Share Price & News

How has CompuGroup Medical SE KGaA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: COP is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: COP's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

2.6%

COP

2.9%

DE Healthcare Services

0.3%

DE Market


1 Year Return

7.9%

COP

15.6%

DE Healthcare Services

47.3%

DE Market

Return vs Industry: COP underperformed the German Healthcare Services industry which returned 15.6% over the past year.

Return vs Market: COP underperformed the German Market which returned 47.3% over the past year.


Shareholder returns

COPIndustryMarket
7 Day2.6%2.9%0.3%
30 Day4.2%3.7%5.0%
90 Day-8.2%-7.7%8.7%
1 Year8.7%7.9%16.4%15.6%52.1%47.3%
3 Year76.8%72.7%74.1%69.8%23.2%12.6%
5 Year113.6%105.1%125.1%115.4%49.8%28.5%

Long-Term Price Volatility Vs. Market

How volatile is CompuGroup Medical SE KGaA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CompuGroup Medical SE KGaA undervalued compared to its fair value and its price relative to the market?

51.95x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: COP (€74.25) is trading above our estimate of fair value (€59.13)

Significantly Below Fair Value: COP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: COP is poor value based on its PE Ratio (52x) compared to the DE Healthcare Services industry average (51.4x).

PE vs Market: COP is poor value based on its PE Ratio (52x) compared to the German market (28x).


Price to Earnings Growth Ratio

PEG Ratio: COP is poor value based on its PEG Ratio (3.8x)


Price to Book Ratio

PB vs Industry: COP is overvalued based on its PB Ratio (6.2x) compared to the DE Healthcare Services industry average (4.3x).


Future Growth

How is CompuGroup Medical SE KGaA forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

13.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: COP's forecast earnings growth (13.7% per year) is above the savings rate (0.07%).

Earnings vs Market: COP's earnings (13.7% per year) are forecast to grow slower than the German market (21% per year).

High Growth Earnings: COP's earnings are forecast to grow, but not significantly.

Revenue vs Market: COP's revenue (6.4% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: COP's revenue (6.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: COP's Return on Equity is forecast to be low in 3 years time (15.7%).


Past Performance

How has CompuGroup Medical SE KGaA performed over the past 5 years?

17.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: COP has high quality earnings.

Growing Profit Margin: COP's current net profit margins (8.4%) are lower than last year (8.5%).


Past Earnings Growth Analysis

Earnings Trend: COP's earnings have grown by 17.3% per year over the past 5 years.

Accelerating Growth: COP's earnings growth over the past year (11.3%) is below its 5-year average (17.3% per year).

Earnings vs Industry: COP earnings growth over the past year (11.3%) underperformed the Healthcare Services industry 11.3%.


Return on Equity

High ROE: COP's Return on Equity (11.5%) is considered low.


Financial Health

How is CompuGroup Medical SE KGaA's financial position?


Financial Position Analysis

Short Term Liabilities: COP's short term assets (€308.1M) exceed its short term liabilities (€290.5M).

Long Term Liabilities: COP's short term assets (€308.1M) do not cover its long term liabilities (€636.3M).


Debt to Equity History and Analysis

Debt Level: COP's debt to equity ratio (79.8%) is considered high.

Reducing Debt: COP's debt to equity ratio has reduced from 191.9% to 79.8% over the past 5 years.

Debt Coverage: COP's debt is well covered by operating cash flow (29.4%).

Interest Coverage: COP's interest payments on its debt are well covered by EBIT (30.8x coverage).


Balance Sheet


Dividend

What is CompuGroup Medical SE KGaA current dividend yield, its reliability and sustainability?

0.67%

Current Dividend Yield


Upcoming Dividend Payment

TodayApr 16 2021Ex Dividend DateMay 20 2021Dividend Pay DateMay 25 20215 days from Ex DividendBuy in the next 34 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: COP's dividend (0.67%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.06%).

High Dividend: COP's dividend (0.67%) is low compared to the top 25% of dividend payers in the German market (3.18%).


Stability and Growth of Payments

Stable Dividend: COP's dividends per share have been stable in the past 10 years.

Growing Dividend: COP's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (35%), COP's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: COP's dividends in 3 years are forecast to be well covered by earnings (25.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Dirk Wossner (51 yo)

0.25

Tenure

Dr. Dirk Wossner has been Chief Executive Officer and Chairman of Management Board at CompuGroup Medical SE & Co. KGaA since January 1, 2021. Dr. Wossner was a Member of the Board of Management at Deutsche...


Leadership Team

Experienced Management: COP's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

Experienced Board: COP's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.


Top Shareholders

Company Information

CompuGroup Medical SE & Co. KGaA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CompuGroup Medical SE & Co. KGaA
  • Ticker: COP
  • Exchange: XTRA
  • Founded: 1987
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: €3.802b
  • Shares outstanding: 53.33m
  • Website: https://www.cgm.com

Number of Employees


Location

  • CompuGroup Medical SE & Co. KGaA
  • Maria Trost 21
  • Koblenz
  • Rhineland-Palatinate
  • 56070
  • Germany

Listings


Biography

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Ph...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/15 18:11
End of Day Share Price2021/04/15 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.